for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

BRIEF-Neubase Therapeutics Reports Q1 Loss Per Share Of $0.26

March 26 (Reuters) - NeuBase Therapeutics Inc:

* NEUBASE THERAPEUTICS REPORTS FINANCIAL RESULTS FOR THE FIRST FISCAL QUARTER OF 2020

* Q1 LOSS PER SHARE $0.26

* Q1 EARNINGS PER SHARE ESTIMATE $-0.32 -- REFINITIV IBES DATA Source text for Eikon: Further company coverage:

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up